spacer
home > ebr > > minimising volume, maximising returns
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

5th Clinical Trials Innovation Programme

27-28 June 2016, Hamburg, Germany

The fourth Clinical Trials Innovation Programme proved to be huge success, the event is back once again and this time it promises to be Bigger and Better! Clinical Trials Innovation Programme is an exclusive, invitation only business platform created with the philosophy to provide a podium to our esteemed clients to gain access to their ideal business partners that are otherwise hard to approach. Hence, “Build Relationships that Matter” is the virtue we propagate.
More info >>

 
News and Press Releases

Data Provides Deeper Understanding of Long-Term Effectiveness and Suitable Populations for Janssen’s IMBRUVICA® (ibrutinib) for the Treatment of Chronic Lymphocytic Leukaemia and Mantle Cell Lymphoma1-3

New data released at the 2016 European Hematology Association
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement